Dexmedetomidine for Attenuation of Pressor Response
Status:
COMPLETED
Trial end date:
2024-05-30
Target enrollment:
Participant gender:
Summary
Direct laryngoscopy and tracheal intubation are usually associated by hemodynamic changes due to increased sympathoadrenal activity which could precipitate serious negative effects in compromised patients . The pressor response could be blunted by dexmedetomidine which is a selective alpha 2 agonist which might provide hemodynamic stability during tracheal intubation.